TEST

Test


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others

Note: Test Details are subject to change without any prior notice. Please confirm with the respective branches for current Details.
 
  C Top

Sno. Test Name Amount  Min Qty Ref. Value
1     C - PEPTIDE ( PP) 750   1 ml Fasting Values : 1.1 - 4.4. ng/ml.
PP values are higher than the fasting levels and are dependent on the nature of Diet.No separate PP reference values are available.

C-Peptide values are decreased in Type 1 Diabetes Mellitus.

Increased in Hyperinsulinism,Obesity and Renal Insufficiency.
2     C - PEPTIDE ( Random) 750   1 ml
3     C - PEPTIDE PROFILE 2800   1 ml
4     C - PEPTIDE ( FASTING) 750   1 ml 1.1-4.4 ng/ml

C-Peptide values are decreased in Type 1 Diabetes Mellitus.

Increased in Hyperinsulinism,Obesity and Renal Insufficiency.
5     C- ANCA 1000   500ul
6     C.M.V Avidity 1000   Low Avidity : Below 30 %
Borderline IgG Avidity : 30 - 40 %
High Avidity : Above 40 %

Detection of a low IgG avidity along with positive IgM & IgG levels is a reliable indicator for Primary (recent) Cytomegalovirus infection. Detection of high IgG avidity along with positive IgG levels shows that the infection has occurred in the past (> 2-4 months).
In some cases, positive Cytomegalovirus IgM antibodies can persist for several months or years after primary infection in an individual. Persistence of low avidity following infection is not uncommon.
Cytomegalovirus Avidity IgG testing results should be interpreted in conjunction with results of Cytomegalovirus IgG and Cytomegalovirus IgM.
In absence of Cytomegalovirus IgG result, avidity testing is inconclusive
7     C.M.V IGG AB (CYTOMEGALO VIRUS) 350   1 ml Less than 0.5 U/ml : Negative
0.5 - 1.0 U/ml : Equivocal
More than or Equal to 1.0 U/ml : Positive

CMV usually causes mild and asymptomatic infections, but may pose a significant medical risk in pregnant women, new born and immunocompromised individuals.

CMV IgG Positive test indicates past or acute infection. BY the age of 25 years most of the population will be positive for CMV IgG.

All results should be interpreted by treating physician with additional relevant diagnostic information and clinical findings.

Precaution: In immunocompromised patients, CMV serology (IgG or IgM antibody titres) may not be reliable and may be misleading in the diagnosis of acute or reactivation of CMV disease. The preferred method for diagnosis is CMV Viral Load Testing.

8     C.M.V IGM AB (CYTOMEGALO VIRUS) 350   1 ML Less than 0.70 COI : Negative
0.70 - 1.00 COI : Equivocal
More than 1.00 COI : Positive

CMV usually causes mild and asymptomatic infections, but may pose a significant medical risk in pregnant women, new born and immunocompromised individuals.

In utero infection can lead to varying degrees of mental retardation, chorioretinitis, hearing loss and neurologic problems.

Equivocal results should be retested after 2 weeks.

Positive test results indicate primary infection, reinfection or reactivation of latent virus. It is recommended to confirm the clinical relevance of reactive results by CMV Viral Load Testing .

All results should be interpreted by treating physician with additional relevant diagnostic information and clinical findings.
9     C.M.V. IGG AB(CSF) 250  
10     C.M.V. IGM AB (CSF) 250  
11     C.R.P. 300   0.5 ml
Neonates Less than 3 weeks :< 4.1 mg/l
Children 2 months to 15 yrs:< 2.8 mg/l


Adults :Less than 5.0 mg/l
12     C.S.F. CULTURE & SENSITIVITY 750  
13     C.S.SPINT OPEN MOUTH 300  
14     C.SPINE EXTENSION 300  
15     C.SPINE FLEXION 300  
16     C.SPINE OBLIQUE LEFT 300  
17     C.SPINE OBLIQUE RIGHT 300  
18     C1 Esterase Inhibitor 3000   195 - 345 mg/L

C1 inactivator deficiency is one of the commonest inherited complement deficiencies leading to Hereditary Angioedema. This deficiency is of two types :

1.Type I ( reduced serum levels of functionally active C1 inactivator)

2.Type II (normal or elevated levels of functionally inactive C1 inactivator)

Acquired C1 esterase inhibitor deficiency is rare and all reported cases have been secondary to Lymphomas or Myelomas.

Please Correlate Clinically.
19     C3 (COMPLEMENT C3) 500   1 ml 90 - 180 mg/dl
20     C4 ( COMPLEMENT C4) 500   0.5 ml 10 - 40 mg/dl.
21     CA 125 700   1 ml Less than 35.0 U/ml

CA 125 levels are increased in Ovarian Tumours of Epithelail origin. Minor elevations are also seen in Benign Ovarian Cysts, Endometriosis , TB of Abdomen and Pelvic Inflammatory Disease. Please correlate with Clinical and Imaging Data.
22     CA 19 - 9 800   1 ml 0 - 39.0 U/ml

CA 19-9 Levels are increased in Obstructive Jaundice, pancreatitis, Cirrhosis of Liver and very high levels in Carcinoma of Pancrease.
HIgher levels of CA 19 -9 alone cannot be used for Diagnosis of CA.Pancreas and must be correlated with other clinical and imaging data.
Can be used for follow up of Patients after surgery for Pancreatic Carcinoma.

23     CA - 125 ( ASCITIC FLUID) 500   No reference value available.
Reference value for Blood : Less than 35.0 U/ml.
24     CA - 15 - 3 800   1 ml Less than 34.5 U/ml

CA 15-3 Levels should be used only for detection of recurrence in previously treated patients and monitoring response to therapy. Should not be used for Diagnosis or Screening for Breast Cancer. For Diagnosis and screening Clinical Breast examination and mammogram should be used.

Note : Kindly note the changes in reference interval.
25     CA 19 - 9 (PANCREATIC FLUID) 600  
26     CA 27.29 3000   Less than 38 U/mL
27     CA 72 - 4 1700   5.6-8.2 U/ml


Elevated CA-72-4 levels are primarily used in monitoring treatment and disease course in patients with gastric cancer. In 70% of relapse cases, CA-72-4 increases prior or concurrently with clinical diagnosis of the relapse. Diagnostic sensitivity of CA-72-4 for gastric cancer increases to 66% when combination of CA-72-4,CEA,CA-125 and CA 19-9 are used. Can be elevated in ovarian and colorectal cancer.
Can also be found in certain non-malignant diseases like pneumonia, pancreatitis, liver cirrhosis and ovarian cysts.
28     Cabbage(f216) - SPECIFIC IgE 600   Less than 0.35 IU/mL: Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL: Very High Positive
29     CALCITONIN 4000   1 ML Female : 5.17 - 9.82 pg/ml
Male : 8.31 - 14.3 pg/ml
30     CALCIUM - DIALYSIS FLUID 150  
31     CALCIUM -SERUM 150   0.5 ML Children
0 - 10 Days : 7.6 - 10.4 mg/dl
10 days - 2 yrs : 9.0 - 11.0 mg/dl
2 - 12 yrs : 8.8 - 10.8 mg/dl
12 - 18 yrs : 8.4 - 10.2 mg/dl

Adults
18 - 60 yrs : 8.6 - 10.0 mg/dl
60 - 90 yrs : 8.8 - 10.2 mg/dl
More than 90 yrs: 8.2 - 9.6 mg/dl

32     Calprotectin- Fecal 3000   Less than 50.0 ug/g: Normal

50 - 200 ug/g: Gray Zone - repeat test after four weeks.

More than 200 ug/g: Positive
Calprotectin increased in Inflammatory Bowel Disease (IBD), Coeliac disease, infectious Colitis, necrotizing enterocilitis and colorectal cancer. The main IBD's are Ulcerative Colitis and Crohn's disease. Calprotectin usually normal in Irritable Bowel Syndrome (IBS).
False elevation of Calprotectin can be observed in patients taking non-steriodal anti-inflammatory drug (NSAID) and infective gastro enteritis.




33     CALR Mutation Analysis 6000  
34     Cancer Syndrome Gene Panel 25000  
35     Candida albicans( m5)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
36     CANNABINOIDS(URINE) 200  
37     CARBAMAZEPINE 600   0.5 ml Therapeutic Level : 4 - 12 Microgm/ml
38     CARDIOLIPIN AB IGA 600   1 ML Less than 12 APL/ml:Negative

12 to 18 APL/ml :Equivocal

More than 18 APL/ml:Positive
39     CARDIOLIPIN AB IGG 600   1 ml Less than 12 GPL/ml:Negative
12 - 18 GPL/ml :Equivocal
More than 18 GPL/ml:Positive
40     CARDIOLIPIN AB IGM 600   1 ML Less than 12 MPL/ml:Negative
12 - 18 MPL/ml :Equivocal
More than 18 MPL/ml:Positive


41     CARNITINE -SERUM 4500  
42     Carrot (f31) - SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
43     Casein ( f 78)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
44     Cat dander ( e100)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
45     Cat epithelium( e1)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
46     CATECHOLAMINES ( 24 HOURS URINE) 5500   10 ML 14 - 110 ug/24hrs

Catecholamines, including dopamine and norepinephrine, are the principal neurotransmitters that mediate a variety of the central nervous system functions, such as motor control, cognition, emotion, memory processing, and endocrine modulation.

Included among catecholamines are epinephrine (adrenaline), norepinephrine (noradrenaline), and dopamine, all of which are produced from phenylalanine and tyrosine.

Release of the hormones epinephrine and norepinephrine from the adrenal medulla of the adrenal glands is part of the fight-or-flight response.

Catecholamines cause general physiological changes that prepare the body for physical activity (fight-or-flight response). Some typical effects are increases in heart rate, blood pressure, blood glucose levels, and a general reaction of the sympathetic nervous system. Some drugs, like tolcapone (a central COMT-inhibitor), raise the levels of all the catecholamines.
47     CATECHOLAMINES ( PLASMA) 8000  
48     CATECHOLAMINES ( SPOT URINE) 5500  
49     CATHEPSIN - G 750   <1.0 Ratio: Negative
1.0 - 2.0 : Weak positive
2.0 - 5.0 : Positive
>5.0 : High Positive
50     Cauliflower(f291) - SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
51     CBC 300  
52     CD 38 1250  
53     CD 48 1250  
54     CD 10 1250  
55     CD 117 1250  
56     CD 11C 1250  
57     CD 13 1250   2 ml
58     CD 14 1250  
59     CD 15 1250  
60     CD 16 1250  
61     CD 19 1250   Normal : 8 % to 18 %

Ref : Int.Journal of Immunopathology & Pharmocology 2017 Jun30 (2) 194-200
62     CD 20 1250   Normal : 10 % to 20 %

Ref : Int.Journal of Immunopathology & Pharmocology 2017 Jun30 (2) 194-200
63     CD 23 1250  
64     CD 24 1250  
65     CD 25 1250  
66     CD 3 1250  
67     CD 33 1250  
68     CD 34 1250   2 ml
69     CD 41 1250  
70     CD 45 1250   2 ML
71     CD 5 1250  
72     CD 55 1250  
73     CD 56 1250  
74     CD 59 1250  
75     CD 64 1250  
76     CD 7 1250  
77     CD4 1250  
78     CD4/CD8 COUNT 1000   2 ML
79     CD8 1250  
80     CEA 750   1 ml Non.Smokers : Upto 5.0 ng/ml
Smokers : Upto 6.5 ng/ml

CEA levels are elevated in Carcinomas of Colon, Lung, Ovaries,Breast, Liver and Pancreas.

CEA levels can be used only for Monitoring and staging of the disease and not for Diagnosis.
81     CEA (ASCITIC FLUID) 500   No reference value available.
82     CEA (CYSTIC FLUID) 500  
83     CEA (PANCREATIC FLUID) 400  
84     CELL COUNT ( CYSTIC FLUID) 60  
85     CELL COUNT ( DIALYSIS FLUID) 60  
86     CELL COUNT ( PERITONEAL FLUID) 100  
87     CELL COUNT (ASCITIC FLUID) 100  
88     CELL COUNT (ASPIRATED FLUID) 60  
89     CELL COUNT(BRONCHIAL WASH) 60  
90     CELL COUNT(CSF) 100  
91     CELL COUNT(PERICARDIAL FLUID) 100  
92     CELL COUNT(PLEURAL FLUID) 100  
93     CELL BLOCK 800  
94     CELLCOUNT (SYNOVIAL FLUID) 100   Appearance : Colourless
WBC : 0 - 200/µl
Neutrophils : Upto 20 %
Lymphocytes : Upto 15 %
Monocytes and Macrophages : Upto 65 %
95     Cephalosporin ( c7) - SPECIFIC IGE 600   1 ML Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
96     CERULOPLASMIN -SERUM 400   1 ml Male : 15 - 30 mg/dl
Female : 16 - 45 mg/dl
97     CERVICAL BIOPSY 500  
98     CERVICAL SPINE AP 300  
99     CERVICAL SPINE AP & LAT 500  
100     CERVICAL SPINE LAT 300  
101     CERVICAL SPINE OBLIQUE 300  
102     CFTR - 4 COMMON MUTATION 5000  
103     Cheese(cheddar type) ( f 81)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
104     CHEST AP VIEW 300  
105     CHEST For RIBS 300  
106     CHEST LATERAL VIEW (RIGHT) 300  
107     CHEST LATERAL VIEW (LEFT) 300  
108     CHEST MEASURMENT 10  
109     CHEST PA VIEW 300  
110     Chicken (f 83) - SPECIFIC IGE 600   1.0 ml Less than 0.35 IU/mL: Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL: Very High Positive
111     Chicken feathers (e 85) - SPECIFIC - IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
112     CHIKUNGUNYA IGM 600   1 Ml Chikungunya virus is transmitted by the bite of infected Aedes aegypti mosquito leading to Dengue like symptoms. Absence of IgM antibody does not exclude the possibility of Chikungunya infection. The test is a preliminary screening test and should not be interpreted in isolation, correlate clinically.
113     CHIKYNGUNYA BY RT PCR 2000  
114     CHLAMYDIA ANTIBODY IgM 600   1 ml Less than 0.90 A.I : Negative
0.90 - 1.10 A.I : Equivocal
More than 1.10 A.I : Positive
115     Chlamydia trachomatis IgA 600   1 ml Less than 0.80 Ratio: Negative
0.80 - 1.10 Ratio: Equivocal
More than 1.10 Ratio: Positive

Interpretation

Chlamydia trachomatis is the common cause of non-gonorrheal urethritis, lymphogranuloma venereum, trachoma and neonatal pneumonia . It also causes ophthalmologic infections. In males, epididymitis and Reiter syndrome occur. In Females, it causes pelvic inflamatory disease and endometritis.

Note: Serological results to chlamydia antibodies must be correlated with clinical history.
116     Chlamydia trachomatis IgG 600   1 ml Less than 0.80 Ratio : Negative
0.80 - 1.10 Ratio : Equivocal
More than 1.10 Ratio : Positive

Interpretation
Chlamydia trachomatis is the common cause of non-gonorrheal urethritis, lymphogranuloma venereum, trachoma and neonatal pneumonia . It also causes ophthalmologic infections. In males, epididymitis and Reiter syndrome occur. In Females, it causes pelvic inflamatory disease and endometritis.

Note: Serological results to chlamydia antibodies must be correlated with clinical history.

117     CHLAMYDIA DNA BY PCR 4000  
118     CHLORIDE ( ASCITIC FLUID) 200   0.5 ml
119     CHLORIDE ( CL - ) 200   Pre mature : 95 - 110 mmol/L
0 - 30 Days : 98 - 113 mmol/L

Adult : 98 - 107 mmol/L
120     CHLORIDE ( CL - )- DIALYSIS FLUID 200  
121     CHLORIDES (CSF) 200   118 - 132 mMol/L
122     CHOCOLATE (f 105) - SPECIFIC IGE 600   1 ml Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
123     CHOLESTEROL - SERUM 150   0.5 ml NCEP guidlines ATP III classification
(Coronary heart disease risk)

Child(upto19 yrs)
Less than 170 mg/dl : Desirable
170 - 199 mg/dl : Borderline High
>= 200 mg/dl : High

Adult(Above 19 yrs)
Less than 200 mg/dl : Desirable
200 - 239 mg/dl : Borderline High
>= 240 mg/dl : High
124     CHOLESTEROL(ASCITIC FLUID) 150  
125     CHOLINESTERASE 600   1.00 ML 3.93 - 10.80 kU/L

Cholinesterase is also called pseudocholinesterase. The main indicators for measuring pseudocholinesterase are:
1 . Monitoring exposure to cholinesterase inhibitors
2. As a liver function test
3. Diagnosis of genetic variants

Decreased levels

1. Organophosphate poisoning
2. Liver diseases like Acute hepatitis, Cirrhosis & Metastatic carcinoma to liver
3. Malnutrition



126     Chromogranin A 5000   Less than 100 ug/l

Chromagranin A is elevated in Chromagranin A secreting neuroendocrine tumours (NETs), such as Pheochromocytomas and carcinoids.
127     CHROMOSOME BREAKAGE SYNDROME 6000  
128     CHYLURIA 100   10 ml
129     CIBD PROFILE ( Chronic Inflammatory Bowel Disease) 5000  
130     CK ( CPK - TOTAL) -SERUM 300   0.5 ml Infants :-
1 Day : < 712 U/L
2 - 5 Days : < 652 U/L
6 Days - 6 Months : < 295 U/L
7 - 12 Months : < 203 U/L
Children
1 - 3 Yrs : < 228 U/L
4 - 6 Yrs : < 149 U/L
Male
7 - 12 Yrs : < 247 U/L
13 - 17 Yrs : < 270 U/L
Female
7 - 12 Yrs : < 154 U/L
13 - 17 Yrs : < 123 U/L

Adult Male : 20 - 200 U/L
Adult Female : 20 - 180 U/L

131     CK - MB - MASS - SERUM 500   1 ml Male :UPTO 6.22 ng/ml
Female :UPTO 4.88 ng/ml
132     Cladosporium herbarum(m2)- SPECIFIC IgE 600   1 ml Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
133     CLAVICLE (LEFT) 300  
134     CLAVICLE (RIGHT) 300  
135     Clinical Exome Sequencing 25000  
136     CLL - TRISOMY 12 BY FISH 3500  
137     CLONIDINE STIMULATION TEST 1000  
138     Clopidogerel(Clopiret) Resistance Test 1000   Less than 5 Ohm ; Shows Antiplatelet effect
More tah 5.1 Ohms : Shows resistance
139     CLOPIDOGREL - GENETIC TEST 4000  
140     Clostridium Difficile (Stool) 1400  
141     CLOT RETRACTION TIME 300  
142     CLOTTING TIME 50   3 - 10 Minutes
143     CME CHOLAMINES, PLASMA 8000  
144     CMV VIRAL LOAD BY RT PCR 4000  
145     CMV DNA BY PCR 4000  
146     COBALT 2000   1.8 µg/L OR less
147     COCAINE(URINE) 200  
148     COCCYX AP & LAT 500  
149     COCCYX LAT 300  
150     Cockroach ( i6 ) - SPECIFIC IgE 600   1 ml Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
151     Cocksfoot(Dacctylis glomerata)( g3)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
152     COCONUT (f 36) - SPECIFIC IgE 600   1 ml Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
153     CODEINE (URINE) 200  
154     COELIAC DISEASE PROFILE 4000   1 ml
155     Cold Agglutinins 4000  
156     COLLAGEN 2000  
157     Colour 0  
158     Common ragweed[Ambrorosia elatior](w1)- SPECI 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
159     COMPLEMENT -TOTAL(CH50) 5000   31 - 60 U/ml

Complement, Total (CH50) - CH50 is a screening test for total complement activity.

Levels of complement may be depressed in genetic deficiency, liver disease, chronic glomerulonephritis, rheumatoid arthritis, hemolytic anemias, graft rejection, systemic lupus erythematosis, acute glomerulonephritis, subacute bacterial endocarditis and cryoglobulinemia.

Elevated complement may be found in acute inflammatory conditions, leukemia, Hodgkin's Disease, sarcoma, and Behcet's Disease.
160     CONE VIEW SELLA 300  
161     CONJUCTIVAL SMEAR FOR GRAM'S STAIN 200  
162     CONSULTATION 250  
163     COOMBS TEST - DIRECT-AUTOMATED 300   1 ML
164     COOMBS TEST - INDIRECT - AUTOMATED 750   1 ml
165     COPPER 500   1 ml MALE : 70 - 140 microgm/dl
FEMALE : 80 - 155 microgm/dl
CHILDREN 6- 12 YRS : 80 - 190 microgm/dl
NEW BORNS : 20 - 70 microgm/dl
PREGNANT WOMEN: 118 - 302 microgm/dl
166     CORONA VIRUS by RT PCR 5000  
167     CORTISOL ( AM) 500   1 ml 6 am - 10 am : 6.02 - 18.4 Microgm/dl
4 pm - 8 pm : 2.68 - 10.5 Microgm/dl

Cortisol levels are increased in Cushings Disease and Syndrome and External Steroid treatment.Combining with ACTH measurement will help in differentiating betwwen Primary and Secondary Hypercortisolism.

Lower Levels are seen in Addisons Disease and Sheehans Syndrome.
168     CORTISOL ( PM) 500   1 ml 7 am - 10 am : 6.02 - 18.4 Microgm/dl
4 pm - 8 pm : 2.68 - 10.5 Microgm/dl

Cortisol levels are increased in Cushings Disease and Syndrome and External Steroid treatment.Combining with ACTH measurement will help in differentiating betwwen Primary and Secondary Hypercortisolism.

Lower Levels are seen in Addisons Disease and Sheehans Syndrome.
169     Crab ( f 23)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
170     CRANIUM - USG 900  
171     CREATININE - DIALYSIS FLUID 100  
172     CREATININE - PLEURAL FLUID 150  
173     CREATININE - SERUM 150   0.5 ml Premature Neonates : 0.29 - 1.04 mg/dl
Full Term Neonates : 0.24 - 0.85 mg/dl
2 - 12 Month : 0.17 - 0.42 mg/dl
1 - 3 yrs : 0.24 - 0.41 mg/dl
3 - 5 yrs : 0.31 - 0.47 mg/dl
5 - 7 yrs : 0.32 - 0.59 mg/dl
7 - 9 yrs : 0.40 - 0.60 mg/dl
9 - 11 yrs : 0.39 - 0.73 mg/dl
11 -13 yrs : 0.53 - 0.79 mg/dl
13 -15 yrs : 0.57 - 0.87 mg/dl

Adult :-
Male : 0.7-1.2 mg/dl
Female : 0.5-0.9 mg/dl
174     CREATININE CLEARANCE 400   5 ml urine & 0.5 ml Serum 71 - 151 ml/min
175     CREATININE(ASCITIC FLUID) 150  
176     CRP (CSF) 250  
177     CRYOGLOBULIN - SERUM 200  
178     Cryoglobulins Qualitative 1000  
179     CRYPTOCOCCUS ANTIGEN - LATEX TEST 600   0.5 ml
180     CSF ANALYSIS 200  
181     CSF FOR AFB STAIN 200  
182     CSF FOR GRAMS STAIN 200  
183     CT - Abdomen Complete -Plain 3000  
184     CT - Abdomen Complete- Palin and Contrast 4000  
185     CT - Abdomenal Angio 7000  
186     CT - Aortic Angiogram 4000  
187     CT - Both Legs Peripheral Angio 10000  
188     CT - Brain -Plain and Contarst 2200  
189     CT - Brain -Plain Study 2000  
190     CT - Brain and Sinuses 1500  
191     CT - Brain Angio 4000  
192     CT - Carotid Angiogram 4000  
193     CT - Cerebral Angiogram 4000  
194     CT - Cervical Spine 2000  
195     CT - Chest -Plain and Contrast 3000  
196     CT - Chest - HRCT 2000  
197     CT - Chest -Plain Study 2000  
198     CT - Contrast Charges (ABD) 1200  
199     CT - Contrast Charges (M) 1000  
200     CT - Contrast Charges (S) 600  
201     CT - Dorsal Spines 3300  
202     CT - ELBOW 2000  
203     CT - Foot 2500  
204     CT - Inner Ear & Temporal Bones 1800  
205     CT - Knee Joint 2800  
206     CT - KUB 3000  
207     CT - Lower Abdomen Plain & Contrast 3300  
208     CT - Lower Abdomen- Plain 2500  
209     CT - Lower Limb 2000  
210     CT - Lumbar Spines 3300  
211     CT - Neck 2600  
212     CT - Orbits 2000  
213     CT - Paranasal Sinuses 1400  
214     CT - Pelvis 2000  
215     CT - Peripheral Angiogram 4000  
216     CT - Pulmonary Angiogram 4000  
217     CT - Renal Angiogram 4000  
218     CT - SCREENING 1000  
219     CT - Sella 2000  
220     CT - SHOULDER 2000  
221     CT - SI Joints 2800  
222     CT - Thoracic Spine 2500  
223     CT - TM Joints 2800  
224     CT - Upper Abdomen - Palin and Contarst 3300  
225     CT - Upper Abdomen - Plain 2500  
226     CT - WRIST 2000  
227     Cucumber(f244) - SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
228     Cultivate oat[Avena sativa]( g14)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
229     Cultivate wheat [Tricum aestivum]( g15)- SPECIFIC 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
230     CULTURE & SENSITIVITY 400  
231     CULTURE & SENSITIVITY - VITEK 720  
232     CULTURE & SENSITIVITYY 400  
233     CYCLOSPORINE 2500   2 ml Post Kidney Transplant Trough Level :
Adults:
0-3 Months : 175 - 200 ng/ml
3-6 MOnths : 150 - 200 ng/ml
6-12 Months: 100 - 125 ng/ml
> 12 Months: 75 - 100 ng/ml

Post Liver Transplant Trough Levels :
0-6 Months : 150 -200 ng/ml
> 6 Months : 100 -150 ng/ml

Toxic Level Post Transplant :

1st Month : More than 500 ng/ml
2nd Month : More than 250 ng/ml.
Note : The levels are given as a guidance only. It may vary in a particular patient with Transplant Type, Other Medications ,and protocols.Samples should be drawn immediately prior to the next dose, for trough Level
234     CYFRA 1500  
235     CYSTATIN C 500   20 to 50 years: 0.47 - 1.09 mg/l
236     CYSTICERCOSIS AB IGG 750   1 ml Less than 9.0 : Negative
9.0 - 11.0 : Equivocal
More than 11.0: Positive
237     CYSTICERCOSIS AB IGM 750   1 ml Less than 0.9 : Negative
0.9 - 1.1 : Equivocal
More than 1.1 : Positive
238     CYSTICERCOSIS ANTIBODY IGM (CSF) 400  
239     CYSTICERCOSIS ANTIBODY IGG(CSF) 400  
240     CYTOLOGY 900  
241     CYTOLOGY ( FNAC - 1 SMEAR) 500  
242     CYTOLOGY FOR MALIGNANT CELLS 900  
 
 
 
  © Copyrights 2009 HITECH DIAGNOSTIC CENTRE. All rights reserved   | About Us| Sitemap